| View |
|
DRP-14515-01
|
Celecoxib
|
Desicox
|
200 mg
|
Capsule
|
Non-Steroidal Anti-inflammatory Drug (NSAID)/ Antirheumatic Drug (Coxib)
|
Pinnacle Life Science Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 April 2024
|
27 September 2028
|
| View |
|
DRP-14530-01
|
Co-Amoxiclav
|
Haiclav
|
1.2 g
|
Powder for Injection (I.V.)
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
Uni Medicolabs
|
India
|
CLIDP Conversion
|
24 April 2024
|
03 October 2028
|
| View |
|
DRP-14589-01
|
Hypromellose
|
Iksharti
|
3 mg/mL (0.3% w/v)
|
Ophthalmic Solution
|
Eye Lubricant
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
24 April 2024
|
19 October 2028
|
| View |
|
DRP-14605-01
|
Apixaban
|
Urania
|
2.5 mg
|
Film-Coated Tablet
|
Anti-Thrombotic Agent (Direct Factor Xa Inhibitor)
|
Baroque Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 April 2024
|
27 October 2028
|
| View |
|
DRP-14696-01
|
Dexamethasone phosphate (as sodium)
|
None
|
4 mg / mL (8 mg/2 mL)
|
Solution for Injection (I.V./I.M.)
|
Corticosteroid
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
07 April 2024
|
10 January 2029
|
| View |
|
DRP-14740-01
|
Quetiapine (as fumarate)
|
Quetigrand 25
|
25 mg
|
Film-Coated Tablet
|
Antipsychotic
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
18 April 2024
|
20 December 2028
|
| View |
|
DRP-14765-01
|
Tranexamic Acid
|
Hematran
|
100 mg/mL
|
Solution for Injection (IV)
|
Antifibrinolytic
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
10 April 2024
|
29 December 2028
|
| View |
|
DRP-14373-02
|
Cilostazol
|
Clostelo 100
|
100 mg
|
Tablet
|
Antithrombotic Agent (Platelet aggregation inhibitor)
|
Cooper Pharma Limited
|
India
|
CLIDP Conversion
|
24 April 2024
|
30 August 2028
|
| View |
|
DRP-14776-01
|
Norepinephrine (as bitartrate)
|
Epinorine 2
|
2 mg/mL (8 mg/4 mL)
|
Solution for Injection (I.V. Infusion)
|
Adrenergic/ Dopaminergic Agent
|
Ultra Laboratories Private Limited
|
India
|
CLIDP Conversion
|
10 April 2024
|
03 January 2029
|
| View |
|
DRP-15018-01
|
Isoflurane
|
Isoflurizz
|
100 % v/v
|
Liquid for Inhalation
|
General Anesthetic (Halogenated Hydrocarbon)
|
Lunan Better Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
27 April 2024
|
20 January 2025
|
| View |
|
DRP-1538-09
|
Diphenhydramine Hydrochloride
|
Senadryl
|
12.5 mg / 5 mL
|
Syrup
|
H1-Receptor Antagonist (Antihistamine)
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
27 April 2024
|
02 January 2027
|
| View |
|
DRP-2942-02
|
Phenylephrine Hydrochloride + Chlorpheniramine Maleate
|
Phenylppex
|
1 mg/0.8 mg per mL
|
Syrup (Oral Drops)
|
Antihistamine/ Nasal Decongestant
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
10 April 2024
|
29 April 2026
|
| View |
|
DRP-3220-09
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Piptaz
|
2 g/250 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Penicillins)
|
Inject Care Parenterals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
07 April 2024
|
06 September 2029
|
| View |
|
DRP-3224-01
|
Atorvastatin (as Calcium)
|
None
|
40 mg
|
Film-Coated Tablet
|
Antihyperlipidemic (HMG-CoA Reductase Inhibitor)
|
XL Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
16 April 2024
|
02 September 2029
|
| View |
|
DRP-3231-18
|
Cefuroxime (as Axetil)
|
Goldfrox
|
250mg/5mL
|
Suspension Powder for Suspension
|
Antibacterial (Cephalosporin)
|
LifeSquare Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
10 April 2024
|
07 September 2028
|
| View |
|
DRP-3600-05
|
Cefuroxime (as sodium)
|
Gorox
|
750 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
CLIDP Conversion
|
15 April 2024
|
14 February 2029
|
| View |
|
DRP-3685-06
|
Simvastatin
|
Qvast
|
20 mg
|
Tablet
|
HMG-CoA Reductase Inhibitor
|
Lifesquare Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
24 April 2024
|
28 October 2028
|
| View |
|
DRP-3715-09
|
Ceftriaxone (as sodium)
|
Ceftripen 1000
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Zazen Pharma Pvt. Ltd.
|
India
|
CLIDP Conversion
|
25 April 2024
|
28 September 2028
|
| View |
|
DRP-4061-08
|
Multivitamins + Dextrose
|
Muzzadex
|
|
Solution for Injection (IV)
|
Parenteral Nutrition
|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
26 April 2024
|
14 June 2026
|
| View |
|
DRP-4210-04
|
Ferrous Sulfate + Folic Acid + Vitamin B Complex
|
Folee Plus
|
|
Capsule
|
Hematinic
|
Lifesquare Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
15 April 2024
|
07 February 2025
|